2026-10-25
Ametek clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
NAS100 26,630 −6.36%
S&P 7,354 −4.36%
GOLD $4,054 −1.44%
BTC $75,513 −6.08%
VIX 28.18 +69.66%
latest tape · as of 06:01 UTC
The Screen · Industrials · Specialty Industrial Machinery
Ametek
AME · a US exchange · USD · Market cap $57.7B · 22,500 employees
AMETEK, Inc.
Not yet scored222.99 USD
Price as of 5 Nov 2026Daily close, not a live quote
Screened 2026-11-05 · the tape above runs as of 06:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price222.99 USD at the 5 Nov 2026 close
- Our value readFair vs our fair value, as of 5 Nov 2026
- Our regime readDistribution, as of 5 Nov 2026
- Ethical screenNot yet scored
- OptionsOpen interest leans heavily to calls (put/call 0.25)
- Last reviewed5 Nov 2026 (1 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
PRICE · ONE YEAR
Our fair-value range: $195.30 to $272.52, base estimate $236.98 (screen dated 2026-11-05).
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.25, read 2026-11-05
- Ethical screen not yet scored
Price222.99 USD
Fair value236.98
Ethical score92.0/100
Value readFairas of 5 Nov 2026
Our investment reviews on this name
2026-11-01Read Markup241.12-7.5% to today Distribution gives way to Markup first Markup read since October
2026-10-26Read Distribution248.52-10.3% to today ✓Accumulation gives way to Distribution
2026-10-19Read Accumulation248.52-10.3% to today Markup gives way to Accumulation
2026-10-02Read Markup250.74-11.1% to today Distribution gives way to Markup after a 5% rise in 11 days
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The full research record, in depth, below
This name holds its distribution label.
Ametek holds its Distribution at $222.99. The statistical read favours the buyers, held for 1 days.
| Phase | Distribution · caution |
| Quantitative state | The statistical read favours the buyers, held for 1 days |
| Price at the screen | $222.99 |
| Valuation | 36.81 trailing · 26.44 forward price to earnings |
| Values screen | Not scored · score 92.0 |
| Beta | 0.96 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 14.59% | Below 33% | Interest-bearing debt is just 14.6% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 9.82% | Below 49% | Money owed to the company is 9.8% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
Ametek clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
2026-09-24
Clears
Ametek clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 15%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
Our analysis reads Fair vs our fair value, as of 5 Nov 2026: moderate competitive moat, 15.00% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-05 screen. The gold marker is the market price at the same screen. A 5.9% discount to the base estimate.
Third-party analyst targets: 18 covering, consensus Buy. The average target sits +27% from the screen price.
Reading the gap · Our more conservative model reads it as roughly fairly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere our models see it going: fair-value estimate $236.98, with a range of $195.30 to $272.52, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsPrecision Parts Maker Priced for Perfection
Every jet engine and power plant runs on sensors and motors that must work first time, every time. Ametek supplies those critical pieces across aerospace and industrial markets, with solid 11% revenue growth, 20% profit margins and a moderate moat. Yet the shares sit 7% above our fair value at a 26.9 times forward earnings multiple that leaves little room for error.
We pass because the valuation already bakes in continued execution and ignores the moderate competitive edge. Analyst targets sit higher, but history shows specialty industrial names rarely sustain premium multiples when growth settles back toward mid-single digits.
The main risk is cyclical exposure in aerospace and power markets, where any slowdown would quickly expose the stretched multiple. Ethical screen clears, yet price leaves no margin of safety. Analysis, not advice.
| Forward P/E | 26.4xpriced for continued growth |
| Trailing P/E | 36.8xexpensive: the price assumes strong growth ahead |
| EPS, trailing | 6.84 |
| EPS, forward | 9.52 |
| Revenue growth | +15.0%steady growth |
| Profit margin | 20.0%healthy profit margins |
| Return on equity | 14.6%a solid return on shareholder capital |
| FCF yield | 2.59% |
| Dividend yield | 0.59% |
| Debt to equity | 0.21minimal debt: a conservative balance sheet |
| Current ratio | 1.21adequate liquidity, worth monitoring |
| Beta | 0.96steadier than the market |
| Short interest, float | 0.02% |
| 52-week range | 188.47 - 261.16 |
| Moat | MODERATE |
| Market cap | $57.7B |
| Employees | 22,500 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Titan Case StudyOur full written analysis of AME: AME Case Study → 2026-07-02
Where & How to TradeAME trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
2026-11-03
Markup $241.12
+0.0% Entry 19
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 24%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (19 analysts) rates it buy, with a mean price target of $259. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-02
Markup $241.12
+0.0% Entry 18
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 24%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (19 analysts) rates it buy, with a mean price target of $259. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-01
Markup · changed $241.12
-4.2% Entry 17
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 4.2% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 24%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (19 analysts) rates it buy, with a mean price target of $259. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-31
Distribution $251.78
+0.0% Entry 16
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 24%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (19 analysts) rates it buy, with a mean price target of $259. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-30
Distribution $251.78
+1.5% Entry 15
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 1.5% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 24%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (19 analysts) rates it buy, with a mean price target of $259. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-29
Distribution $248.13
-0.2% Entry 14
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.2% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 24%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (19 analysts) rates it buy, with a mean price target of $259. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-28
Distribution $248.52
+0.0% Entry 13
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 24%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (19 analysts) rates it buy, with a mean price target of $259. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-27
Distribution $248.52
+0.0% Entry 12
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 24%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (19 analysts) rates it buy, with a mean price target of $259. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-26
Distribution · changed $248.52
+0.0% Entry 11
The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 24%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (19 analysts) rates it buy, with a mean price target of $259.
2026-10-19
Accumulation · changed $248.52
0.0% Entry 10
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 24%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (19 analysts) rates it buy, with a mean price target of $259.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Paycom Q3 Earnings Beat Estimates on Revenue Growth, Margin Gains Yahoo Finance · 16h ago
- Avnet Q1 Earnings Beat Estimates on Record Sales & Strong Demand Yahoo Finance · 16h ago
- Qnity's Q3 Earnings Beat Estimates on AI Demand, Outlook Raised Yahoo Finance · 16h ago
- JKHY Q1 Earnings Beat Estimates on Cloud & Payments Growth Yahoo Finance · 17h ago
- The New York Times Q3 Earnings Beat on Digital Subscription Growth Yahoo Finance · 18h ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
ROKRockwell Automation
SDVKYSandvik AB (publ)
CMICummins
ITWIllinois Tool Works
ATLCYAtlas Copco AB (publ)
EMREmerson Electric
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-07 | STANAGE NICKIE LEE | Director | 760 | $178,395 | |
| 2026-03-24 | AMATO THOMAS A | Director | 530 | $114,893 | |
| 2026-03-20 | SPERANZA EMANUELA | Officer | 574 | · | |
| 2026-03-18 | SPERANZA EMANUELA | Officer | 296 | · | |
| 2026-03-18 | OSCHER RONALD J | Officer | 1,300 | $276,601 | |
| 2026-03-18 | CIAMPITTI TONY J. | Officer | 1,300 | $276,601 | |
| 2026-03-18 | STEFANY SUZANNE L. | Director | 950 | $202,132 | |
| 2026-03-18 | HERMANCE DAVID F. | Officer | 1,240 | $263,835 | |
| 2026-03-18 | AMODEI ROBERT J. | Officer | 360 | $76,597 | |
| 2026-03-18 | CARPENTER TOD E | Director | 950 | $202,132 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-09-25 | Ro Khanna | Democrat | sell | 15K–50K |
| 2026-09-25 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-09-25 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-09-25 | Ro Khanna | Democrat | sell | 15K–50K |
| 2026-09-25 | Ro Khanna | Democrat | sell | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $232.16 | -4.4% | · | $956 | -4.4% |
| 2 months | $234.91 | -5.5% | · | $945 | -5.5% |
| 3 months | $215.23 | +3.1% | $0.34 | $1,033 | +3.3% |
| 6 months | $203.52 | +9.0% | $0.34 | $1,092 | +9.2% |
| 1 year | $178.70 | +24.2% | $1.27 | $1,249 | +24.9% |
| 2 years | $170.76 | +30.0% | $2.42 | $1,314 | +31.4% |
| 3 years | $147.63 | +50.3% | $3.20 | $1,525 | +52.5% |
| 5 years | $131.71 | +68.5% | $5.18 | $1,724 | +72.4% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever AME does next, these words stay.
Membership
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.